Perrigo (PRGO) EBITDA Margin Growth (5y) (2017 - 2026)
Perrigo (PRGO) EBITDA Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Perrigo | 1.98 Bn | 1.58 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 1,513.00 |
| Mar 28, 2026 | -4,350.00 |
| Dec 31, 2025 | -11,891.00 |
| Sep 27, 2025 | -87.00 |
| Jun 28, 2025 | -231.00 |
| Mar 29, 2025 | -348.00 |
| Dec 31, 2024 | 1,283.00 |
| Sep 28, 2024 | 283.00 |
| Jun 29, 2024 | -727.00 |
| Mar 30, 2024 | -1,381.00 |
| Dec 31, 2023 | -1,034.00 |
| Sep 30, 2023 | 1,629.00 |
| Jul 1, 2023 | -322.00 |
| Apr 1, 2023 | -874.00 |
| Dec 31, 2022 | -968.00 |
| Oct 1, 2022 | -1,018.00 |
| Jul 2, 2022 | -1,264.00 |
| Apr 2, 2022 | -874.00 |
| Dec 31, 2021 | 4,063.00 |
| Oct 2, 2021 | 15,842.00 |